Tobacco Science and Technology
Tobacco Science and Technology is a peer reviewed journal since 2013 up to now. The journal is monthly publishing journal.The main scope of Tobacco Science and Technology) is Agricultural engineering/Agricultural science, Biological Engineering/ Biological science, bio-chemistry, chemistry, public health, pharmaceutical science and so on. Our journal welcome original papers from everywhere in the world.
Volume 58 , Issue 04
20 Nov 2025SUBMISSION DEADLINE
Day
Hour
Min
Sec
Volume - 58 , Issue 04
30 Nov 2025PUBLISH ON
AIM AND SCOPES
Tobacco Science and Technology
Agricultural engineering
Agricultural science
Biological Engineering
Biological science
bio-chemistry
chemistry
public health
pharmaceutical science
All Published Jurnal
Tobacco Science and Technology
Study of the Agronomic, Biochemical and Yield Components of Mirabelle Pea Varieties (Pisum sativum subsp. sativum ), exposed to Oxidative Stress by Difenconazole and Responses of the Antioxidant Defense System
The use of phytosanitary products is called into question, with the risks they can cause for the environment and human health. These chemical solutions can cause considerable damage to crops and can cause an overproduction of ROS (Reactive Oxygen Species) which results in chlorosis and necrosis visible to the naked eye, up to the premature death of plants. This scientific contribution aims to verify in the laboratory the effect of a Difenconazole on the agronomic parameters, the biochemical indicators and the components of the yield of a pea legume (Pisum sativum subsp. Sativum var. Sativum).
Range of intestinal microflora in patients with allergic rhinitis, atopic bronchial asthma and urticaria
Range of intestinal microflora in patients with allergic rhinitis, atopic bronchial asthma and urticariaRange of intestinal microflora in patients with allergic rhinitis, atopic bronchial asthma and urticariaRange of intestinal microflora in patients with allergic rhinitis, atopic bronchial asthma and urticariaRange of intestinal microflora in patients with allergic rhinitis, atopic bronchial asthma and urticariaRange of intestinal microflora in patients with allergic rhinitis, atopic bronchial asthma and urticariaRange of intestinal microflora in patients with allergic rhinitis, atopic bro
Identification of a new pathogen causing tobacco spot blight in Guangxi
Tobacco (Nicotiana tabacum L.), which creates jobs for 33 million people and contributes two trillion dollars’ tax annually, is one of the most important economic plants globally. However, tobacco is seriously threatened by numerous diseases during production. Previously, the field survey of tobacco diseases was conducted in the Guizhou and Guangxi provinces, the two main tobacco-producing areas in China. A serious leaf spot disease, with a 22% to 35% incidence, was observed in farming plants. In order to determine the causal agents, we collected the disease samples and isolated
Comprehensive evaluation of chemical quality of flue-cured tobacco based on improved TOPSIS method
In order to improve the scientific and rationality of power quality (PQ) comprehensive evaluation, an improved Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS) strategy in consideration of the correlation between indices is proposed to evaluate PQ. The strategy overcomes the shortcomings of the traditional methods that ignore the correlation between PQ performance parameters. Firstly, the AHP-entropy weight (EW) method is obtained by combining the improved analytic hierarchy process (AHP) and the EW method, and the combined weights of the PQ indices are calculated.
Inactivation mechanism of tobacco mosaic virus with composite sodium chlorite
Using half-leaf method O,O′-diisopropyl (3-(L-1-(benzylamino)-1-oxo-3- phenylpropan-2-yl)thioureido)(phenyl)methyl phosphonate (2009104) was studied for its activity on tobacco mosaic virus (TMV). It showed good curative activity in vivo and the curative activity at 500 μg/mL was found to be 53.3%. In vivo treatment with the control agent Ningnanmycin at 500 μg/mL resulted in 51.2% inhibition and curative inhibition rates respectively. Dot-ELISA test was employed to verify the efficacy of activity of compound 200910 for anti-TMV activity. The mechanism of action of compound 200